1 completed, 1 withdrawn. 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow CT-P63: new trials by email Literature Review of CT-P63 trials Research Report on CT-P63
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate the Safety and Efficacy of Inhaled CT-P63 and CT-P66 Combination Therapy in Symptomatic Patients With COVID-19 Not Requiring Supplemental Oxygen CT-P63 and CT-P66 / Placebo - COVID-19 | Phase 3 | Withdrawn | Celltrion | 2022-04-01 | 2022-07-25 | |
| To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy Subjects CT-P63, Placebo - SARS-CoV-2 Infection | Phase 1 | Completed | Celltrion | 24 | 2021-10-11 | 2022-08-11 |
COVID-19 (2)
Celltrion (2)
Poland (1)